News on muscle relaxants

  • C. Melloni
  • F. Antolini
  • F. Sfogliaferri
Conference paper


The big news in the field of neuromuscular blocking agents is ... that there are no new drugs on the horizon. The shortage of money in the field of neuromuscular research derives from the simple fact that the pharmaceutical companies have no money to invest in market niches and perhaps from the perceived evidence that the drugs we have today are already highly sophisticated and there is no absolute need to improve them. Organon tried to launch a new fast-onset/fast-offset drug (rapacuronium), but it had dangerous side effects on the airways, especially a worrying incidence of bronchospasm and oxygen desaturations [1], and was therefore withdrawn from the formularies after a promising start. We are still short of a drug with clinical time actions similar to those of succinylcholine, and this is still a goal of pharmaceutical research in the field of the neuromuscular blocking agents, pushed by the continuous growth of day surgery/day anaesthesia.


Neuromuscular Blockade Neuromuscular Block Neuromuscular Blocking Agent Reversal Agent Adductor Pollicis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    White PF (2002) Rapacuronium: why did it fail as a replacement for succinylcholine? Br J Anaesth 88; 163–65PubMedCrossRefGoogle Scholar
  2. 2.
    Baillard C, Gehan G, Reboul-Marty J et al (2000) Residual curarization in the recovery room after vecuronium. Br J Anaesth 84: 394–395PubMedCrossRefGoogle Scholar
  3. 3.
    Hayes AH, Mirakhur RK, Breslin DS et al (2001) Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 56: 312–318PubMedCrossRefGoogle Scholar
  4. 4.
    Kim KS, Lew SH, Cho HY, Cheong MA (2002) Residual paralysis induced by either vecuronium or rocuronium after reversal with pyridostigmine. Anesth Analg 95: 1656–1660PubMedCrossRefGoogle Scholar
  5. 5.
    Camu G, de Baerdemaeker L, den Blauwen N et al (2002) Postoperative residual curarization with cisatracurium and rocuronium infusions. Eur J Anaesthesiol 19: 129–134Google Scholar
  6. 6.
    Palin R, Clark JK, Cowley P et al (2002) Novel piperidinium and pyridinium agents as water-soluble acetylcholinesterase inhibitors for the reversal of neuromuscular blockade. Bioorg Med Chem Lett 12: 2569–2572PubMedCrossRefGoogle Scholar
  7. 7.
    Cameron KS, Fielding L, Mason R et al (2002) Anionic cyclophanes as potential reversal agents of muscle relaxants by chemical chelation. Bioorg Med Chem Lett 12: 753–755PubMedCrossRefGoogle Scholar
  8. 8.
    Adam JM, Bennett DJ, Born A et al (2002) Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem 45: 1806–1816PubMedCrossRefGoogle Scholar
  9. 9.
    Fuchs-Buder T, Mencke T (2001) Use of reversal agents in day care procedures (with special reference to postoperative nausea and vomiting). Eur J Anaesthesiol Suppl 23: 53–59PubMedGoogle Scholar
  10. 10.
    Berg H, Viby-Mogensen J, Roed J et al (1997) Residual neuromuscular block is a risk factor for postoperative pulmonary complications: a prospective, randomised and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiol Scand 41: 1095–1103PubMedCrossRefGoogle Scholar
  11. 11.
    Kirkegaard H, Heier T, Caldwell JE (2002) Efficacy of tactile-guided reversal from cisatracurium-induced neuromuscular block. Anesthesiology 96: 45–50PubMedCrossRefGoogle Scholar
  12. 12.
    Eikermann, M, Groeben H, Husing J, Peters J (2003) Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 98: 1333–1337PubMedCrossRefGoogle Scholar
  13. 13.
    Lysakowski C, Fuchs-Buder T, Tassonyi E (2000) Mivacurium or vecuronium for paediatric ENT surgery. Clinical experience and cost analysis. Anaesthesist 49: 387–391Google Scholar
  14. 14.
    Plaud B, Debaene B, Donati F (2001) The corrugator supercilii, not the orbicularis oculi, reflects rocuronium neuromuscular blockade at the laryngeal adductor muscles. Anesthesiology 95: 96–101PubMedCrossRefGoogle Scholar
  15. 15.
    Hemmerling TM, Schmidt J, Wolf T et al (2001) Intramuscular versus surface electromyography of the diaphragm for determining neuromuscular blockade. Anesth Analg 92: 106–111PubMedCrossRefGoogle Scholar
  16. 16.
    Itoh H, Shibata K, Yoshida M et al (2000) Neuromuscular monitoring at the orbicularis oculi may overestimate the blockade in myasthenic patients. Anesthesiology 93: 1194–1197PubMedCrossRefGoogle Scholar
  17. 17.
    Hemmerling TM, Schmidt J, Hanusa Q et al (2000) Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth 85: 856–860PubMedCrossRefGoogle Scholar
  18. 18.
    Hemmerling TM, Schurr C, Walter S et al (2000) A new method of monitoring the effect of muscle relaxants on laryngeal muscle using surface laryngeal electromyography. Anesth Analg 90: 494–497PubMedGoogle Scholar
  19. 19.
    Hemmerling TM, Schmidt J, Wolf T et al (2000) Comparison of succinylcholine with two doses of rocuronium using a new method of monitoring neuromuscular block at the laryngeal muscles by surface laryngeal electromyography. Br J Anaesth 85: 251–255PubMedCrossRefGoogle Scholar
  20. 20.
    Hemmerling TM, Schmidt J, Wolf T et al (2001) Intramuscular versus surface electromyography of the diaphragm for determining neuromuscular blockade. Anesth Analg 92: 106–111PubMedCrossRefGoogle Scholar
  21. 21.
    Hemmerling TM, Schmidt J, Hanusa C et al (2001) The lumbar paravertebral region provides a novel site to assess neuromuscular block at the diaphragm. Can J Anesth 48: 356–360PubMedCrossRefGoogle Scholar
  22. 22.
    Bellemare F, Couture J, Donati F (2000) Temporal relation between acoustic and force responses at the adductor pollicis during nondepolarizing neuromuscular block. Anesthesiology 93: 646–652PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 2004

Authors and Affiliations

  • C. Melloni
  • F. Antolini
  • F. Sfogliaferri

There are no affiliations available

Personalised recommendations